Identification of potential prognostic markers for knee osteoarthritis by serum proteomic analysis

Biomarker Insights

Volumn 8, Issue , 2013, Pages 85-95

  Takinami, Yoshihiko ^a   Yoshimatsu, Shinya ^a   Uchiumi, Takaoki ^a   Toyosaki Maeda, Tomoko ^a   Morita, Atsushi ^a   Ishihara, Takeshi ^a   Yamane, Shoji ^a   Fukuda, Isao ^a   Okamoto, Hiroyuki ^a   Numata, Yoshito ^a   Fukui, Naoshi ^b  

^a SHIONOGI AND CO LTD   (Japan)

^b SAGAMIHARA NATIONAL HOSPITAL   (Japan)

Author keywords

Biomarker; Osteoarthritis; Proteomics; Surface enhanced laser desorption ionization (SELDI)

Indexed keywords

APOLIPOPROTEIN C1; APOLIPOPROTEIN C3; PREALBUMIN; PROTEIN ANTIBODY;

ADULT; AMINO TERMINAL SEQUENCE; ANALYZER; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC KIT; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; IMMUNOPRECIPITATION; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PREDICTION; PROGNOSIS; PROTEIN DETERMINATION; PROTEOMICS; RETROSPECTIVE STUDY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; VALIDATION PROCESS;

EID: 84881042313     PISSN: 11772719     EISSN: None     Source Type: Journal    
DOI: 10.4137/BMI.S11966     Document Type: Article

References (33)

1. Murphy L, Schwartz TA, Helmick CG, et al. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 2008;59:1207-13.
2. Jinks C, Jordan K, Croft P. Osteoarthritis as a public health problem: the impact of developing knee pain on physical function in adults living in the community: (KNEST 3). Rheumatology (Oxford). 2007;46:877-81.
3. Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA. Insurer and out-of-pocket costs of osteoarthritis in the US: Evidence from national survey data. Arthritis Rheum. 2009;60:3546-53.
4. Kim S. Changes in surgical loads and economic burden of hip and knee replacements in the US: 1997-2004. Arthritis Rheum. 2008;59:481-8.
5. Fukui N, Yamane S, Ishida S, et al. Relationship between radiographic changes and the symptoms or physical examination findings in the subjects with symptomatic medial knee osteoarthritis: a three-year prospective study. BMC Musculoskelet Disord. 2010;11:269-78.
6. Emrani PS, Katz JN, Kessler CL, et al. Joint space narrowing and Kellgren-Lawrence progression in knee osteoarthritis: an analytic literature synthesis. Osteoarthritis Cartilage. 2008;16:873-82.
7. Ruiz-Romero C, Blanco FJ. Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritis. Osteoarthritis and Cartilage. 2010;18:500-9.
8. Hutchens T, Yip T. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom. 1993;7:576-80.
9. Reddy G, Dalmasso EA. SELDI Proteins Chip® Array Technology: protein-based predictive medicine and drug discovery applications. J Biomed Biotechnol. 2003;4:237-41.
10. Petricon EF, Liotta LA. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr Opin Biotechnol. 2004;15:24-30.
11. Harezlak J, Wang M, Christiani D, Lin X. Quantitative quality-assessment techniques to compare fractionation and depletion methods in SELDI-TOF mass spectrometry experiments. Bioinformatics. 2007;23:2441-8.
12. Keshishian H, Addona T, Burgess M, Kuhn E, Carr SA. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics. 2007;6: 2212-29.
13. Lee IN, Chen CH, Sheu JC, et al. Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach. Proteomics. 2006;6:2865-73.
14. Melle C, Ernst G, Scheibner O, et al. Identification of specific protein markers in microdissected hepatocellular carcinoma. J Proteome Res. 2007;6: 306-15.
15. Gray RD, MacGregor G, Noble D, et al. Sputum proteomics in inflammatory and suppurative respiratory diseases. Am J Respir Crit Care Med. 2008; 178:444-52.
16. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29:1039-49.
17. Peterfy C, Li J, Zaim S, et al. Comparison of fixed-flexion positioning with fluoroscopic semi-flexed positioning for quantifying radiographic joint-space width in the knee: test-retest reproducibility. Skeletal Radiol. 2003;32:128-32.
18. Kothari M, Guermazi A, von Ingersleben G, et al. Fixed-flexion radiography of the knee provides reproducible joint space width measurements in osteoarthritis. Eur Radiol. 2004;14:1568-73.
19. Vilím V, Olejárová M, Machácek S, et al. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage. 2002;10:707-13.
20. Deberg MA, Labasse AH, Collette J, et al. One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression. Osteoarthritis Cartilage. 2005;13:1059-65.
21. Sharif M, Shepstone L, Elson CJ, Dieppe PA, Kirwan JR. Increased serum C reactive protein may reflect events that precede radiographic progression in osteoarthritis of the knee. Ann Rheum Dis. 2000;59:71-4.
22. Sharif M, George E, Shepstone L, et al. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum. 1995;38:760-7.
23. Pavelka K, Forejtová S, Olejárová M, et al. Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis. Osteoarthritis Cartilage. 2004;12:277-83.
24. Nelson AE, Golightly YM, Kraus VB, et al. Serum transforming growth factor-beta 1 is not a robust biomarker of incident and progressive radiographic osteoarthritis at the hip and knee: the Johnston County Osteoarthritis Project. Osteoarthritis Cartilage. 2010;18:825-9.
25. Botha-Scheepers S, Watt I, Slagboom E, et al. Innate production of tumour necrosis factor alpha and interleukin 10 is associated with radiological progression of knee osteoarthritis. Ann Rheum Dis. 2008;67:1165-9.
26. De Bock M, de Seny D, Meuwis MA, et al. Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. J Biomed Biotechnol. 2010;2010:906082.
27. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002;1:845-67.
28. Sowers M, Karvonen-Gutierrez CA, Palmieri-Smith R, et al. Knee osteoarthritis in obese women with cardiometabolic clustering. Arthritis Rheum. 2009;61:1328-36.
29. Tsezou A, Iliopoulos D, Malizos KN, Simopoulou T. Impaired expression of genes reguilating cholesterol effulux in human osteoarthritic chondrocytes. J Orthopaedic Res. 2010;28:1033-9.
30. Naishiro Y, Suzuki C, Kimura M, et al. Plasma analysis of rheumatoid arthritis by SELDI. Jpn J Clin Immunol. 2007;30:145-50
31. Takeuchi T, Nakanishi T, Tabushi Y, et al. Serum protein profile of rheumatoid arthritis treated with anti-TNF therapy (infliximab). J Chromatography B Analyt Technol Biomed Life Sci. 2007;855:66-70.
32. Mizuguchi M, Hayashi A, Takeuchi M, et al. Unfolding and aggregation of transthyretin by the truncation of 50 N-terminal amino acids. Proteins. 2008;72:261-9.
33. Zhang Z, Bast RC Jr, Yu Y, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2004;64:5882-90.